Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 1 Characteristics of EU-Meds Study, 2014

From: Nonmedical use of prescription drugs in the European Union

Characteristic Percentagea Total No.b
Country   
 Denmark 12.4 2,732
 Germany 24.9 5,511
 Great Britain 25.3 5,572
 Spain 24.9 5,507
 Sweden 12.5 2,748
Sex   
 Male 50.3 9,725
 Female 49.7 12,245
Race   
 White 93.0 17,475
 Non-white 7.0 1,413
Age, years   
 12–17 9.2 2,032
 18–29 32.9 7,048
 30–49 57.9 12,990
Marital Statusc   
 Never married 45.5 8,775
 Married/cohabitating 33.2 7,032
 Divorced/separated/widowed 21.3 4,231
Employment   
 Full/Part time 52.5 12,133
 Unemployed 11.2 2,268
 Student 18.4 3,950
 Not in labor force 17.9 3,719
Lifetime NMPDU   
 Stimulant 7.0 1,302
 Opioid 13.5 2,682
 Sedative 10.9 2,203
Past-Year NMPDU   
 Stimulant 2.8 498
 Opioid 5.0 949
 Sedative 5.8 1,099
Illicit Drug Use, Lifetimed 38.1 7,856
Illicit Drug Use, Past-Yeard 11.7 2,200
  1. NMPDU nonmedical prescription drug use
  2. aEstimate based on weighted data
  3. bSample size is unweighted
  4. cSample restricted to ages 18 or older
  5. dIllicit drug use includes marijuana, cocaine, heroin, methamphetamine, hallucinogens, inhalants, and designer drugs